FACTORS AND PATHOGENESIS OF SOMATIC AND HEREDITARY DISEASES OF CONNECTIVE TISSUE.
Article Sidebar
Main Article Content
Abstract
Connective tissue diseases (CTDs) are a diverse group of disorders affecting the body’s structural matrix. These can be broadly classified into hereditary (genetic) and somatic (acquired) categories. Hereditary connective tissue disorders are caused by genetic mutations in extracellular matrix components (such as collagen, elastin, fibrillin, or enzymes modifying these proteins), leading to multi-system effects. Examples include Marfan syndrome, Ehlers–Danlos syndrome, and osteogenesis imperfecta, where mutations in FBN1, COL1A1/COL1A2, or related genes alter tissue integrity. In contrast, somatic CTDs are mostly autoimmune or inflammatory, characterized by autoantibody production and immune-complex deposition (e.g. systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis). Etiologically, hereditary CTDs hinge on Mendelian inheritance and gene-environment interplay, whereas somatic CTDs arise from a combination of genetic susceptibility (e.g. HLA haplotypes) and environmental triggers (infections, toxins, hormones, or physical factors). Pathogenetically, structural gene defects lead to connective tissue weakness or malformation (e.g. defective collagen in bone and skin), while autoimmune CTDs involve immune-mediated tissue damage – for example, immune-complex deposition in SLE or fibroblast activation and fibrosis in systemic sclerosis. Morphological changes range from disorganized collagen/elastin fibers and tissue laxity in genetic disorders, to chronic synovitis and erosive joint lesions in rheumatoid arthritis, or dense dermal sclerosis in scleroderma. Clinically, CTDs present with multi-system involvement (skin, joints, cardiovascular, ocular, etc.), and diagnosis relies on integration of clinical criteria, imaging, immunologic testing (ANA and specific autoantibodies), and genetic or histopathologic confirmation. Understanding the interplay of genetic mutations, immune dysregulation, and environmental factors is crucial for diagnosis and management of these connective tissue pathologies.
Article Details
Section
References
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Committee on Selected Heritable Disorders of Connective Tissue and Disability. Selected Heritable Disorders of Connective Tissue and Disability. Washington (DC): National Academies Press (US); 2022. Ch. 2: Overview of Hereditary Disorders of Connective Tissue. Connective tissue includes cells, collagen and elastic fibers, and ground substance (proteoglycans, hyaluronic acid). These heritable disorders are “a heterogeneous group of many inherited disorders”.
Peterson LK. Connective Tissue Diseases – Systemic Autoimmune Rheumatic Diseases. ARUP Consult. 2025. Connective tissue or systemic autoimmune rheumatic diseases (SARDs) are characterized by autoantibodies; the SARDs include SLE, Sjögren’s, MCTD/UCTD, systemic sclerosis, and idiopathic inflammatory myopathies.
Gomes-Coelho S, Almeida AG. Marfan syndrome revisited: From genetics to clinical practice. Rev Port Cardiol. 2020;39(4):215-226. Marfan syndrome is an autosomal dominant CT disease (∼1:5000) caused by FBN1 mutations in 90% of cases. Fibrillin-1 mutations disrupt microfibrils and local TGF-β signaling, impairing connective tissue integrity and predisposing to aortic aneurysms and dissections. Early diagnosis (Ghent criteria) and management (beta-blockers, surgery) improve outcomes.
Miklovic T, Sieg VC. Ehlers-Danlos syndrome. StatPearls. 2023. EDS is a group of hereditary CT disorders with hyperextensible skin, joint hypermobility, atrophic scarring, and vessel fragility. Inheritance is usually autosomal dominant (≈50% de novo). Different subtypes have distinct collagen or enzyme gene defects. Complications include arterial rupture, organ perforation, and joint dislocations.
Subramanian S et al. Osteogenesis Imperfecta. StatPearls. 2023. OI is a genetic disorder of connective tissue due to defects in type I collagen synthesis. It causes bone fragility and fractures, with features like blue sclerae and dentinogenesis imperfecta. Most cases involve mutations in COL1A1 or COL1A2.
Varga J et al. Systemic sclerosis (scleroderma): From pathogenesis to novel therapies. Blood. 2021. (not explicitly cited above). Pathogenesis involves early endothelial injury and dysregulated T-cell and cytokine responses leading to fibrosis.
Kumar S. Genetics and Pathogenesis of Connective Tissue Disease-Associated Interstitial Lung Disease. Indian J Rheumatol. 2021;16(Suppl 1):S29-S38. The pathogenesis of CTD-ILD, and by extension many CTDs, follows the paradigm of genetic predisposition plus environmental trigger. Lung fibrosis in CTDs is a self-perpetuating cycle of inflammation and fibroblast activation.
Rodríguez-Reyna TS, Gómez-Martín D, Funes SC. Integrating the autoimmune connective tissue diseases for the medical student: A classification proposal based on pathogenesis and clinical phenotype. Heliyon. 2023;9(10):e19355. This review clusters SLE, APS, RA, Sjögren’s, and SSc by immune phenotype. SLE is an immune-complex disease with vascular injury; RA involves chronic synovitis with citrullination-triggered autoimmunity; SSc involves endothelial injury and fibroblast overactivation. It emphasizes the shared pathomechanisms (autoantibodies, cytokines) among CTDs.
Holbrook KA, Byers PH. Skin is a window on heritable disorders of connective tissue. Am J Med Genet. 1989;34(1):105-121. Studies of skin in inherited CTDs demonstrate that matrix components (collagens, elastin, proteoglycans) are interdependent, so a defect in one component can disrupt overall tissue organization. Characteristic ultrastructural patterns (e.g. fragmented elastic fibers, abnormal collagen fibrils) may confirm diagnosis.
Tarabichi J et al. Ultrastructural pathology of aortic dissections in patients with Marfan syndrome. (paraphrased) Study notes that both Marfan and non-Marfan dissections share medial degeneration, but the underlying cause in Marfan is fibrillin-1 mutation.
O’Neill J et al. Dermatomyositis. StatPearls. 2023. (not directly cited, but for concept) In DM, complement-mediated microangiopathy and CD4 T-cell infiltrates cause perimysial muscle fiber damage.
Nonaka D et al. Mixed connective tissue disease. Am J Clin Pathol. 2013. (not cited above) describes overlapping features and U1-RNP antibodies.
Cho JH, Gregersen PK. Genetics and the Pathogenesis of SLE. Annu Rev Med. 2022. (not cited above)
Rheumatology textbooks/articles. (Various sources for classification and disease definitions)
ARUP Consult Laboratory. Connective Tissue Diseases – Systemic Autoimmune Rheumatic Diseases. ARUP Laboratory, 2025. This resource details testing for SARDs, noting that ANA (by immunofluorescence) is the recommended screening test and lists organ-specific symptomatology for SLE, Sjögren’s, SSc, etc.
Tan EM et al. 1982 Revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1982. (not quoted, used for context)
[Additional pathology and rheumatology literature on each disease’s histopathology and classification.]